

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Golgi transport vesicle coating (GO:0048200) | 5.74105554 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 5.74105554 |
| 3 | modulation by symbiont of host immune response (GO:0052553) | 5.50307446 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 5.50307446 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 5.50307446 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.50307446 |
| 7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.50307446 |
| 8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.50307446 |
| 9 | neutrophil activation involved in immune response (GO:0002283) | 5.26896518 |
| 10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.19564256 |
| 11 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.02474825 |
| 12 | microglial cell activation (GO:0001774) | 4.70511987 |
| 13 | macrophage activation involved in immune response (GO:0002281) | 4.42640737 |
| 14 | keratan sulfate catabolic process (GO:0042340) | 4.31717372 |
| 15 | signal peptide processing (GO:0006465) | 4.20545717 |
| 16 | oligosaccharide catabolic process (GO:0009313) | 4.12197200 |
| 17 | positive regulation of monocyte chemotaxis (GO:0090026) | 4.02133936 |
| 18 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.91160096 |
| 19 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.85532704 |
| 20 | positive regulation of interferon-alpha production (GO:0032727) | 3.85192016 |
| 21 | amino sugar catabolic process (GO:0046348) | 3.80928546 |
| 22 | negative regulation of interleukin-12 production (GO:0032695) | 3.79507766 |
| 23 | regulation of monocyte chemotaxis (GO:0090025) | 3.72802025 |
| 24 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.72448657 |
| 25 | phagocytosis, engulfment (GO:0006911) | 3.71554386 |
| 26 | negative regulation of mast cell activation (GO:0033004) | 3.67064421 |
| 27 | response to thyroid hormone (GO:0097066) | 3.60463981 |
| 28 | regulation of interferon-alpha production (GO:0032647) | 3.60026309 |
| 29 | macrophage activation (GO:0042116) | 3.56420274 |
| 30 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.55715257 |
| 31 | apoptotic cell clearance (GO:0043277) | 3.55646754 |
| 32 | response to peptidoglycan (GO:0032494) | 3.53387187 |
| 33 | positive regulation of mast cell activation (GO:0033005) | 3.50386115 |
| 34 | glycosphingolipid catabolic process (GO:0046479) | 3.47671246 |
| 35 | protein retention in ER lumen (GO:0006621) | 3.47625788 |
| 36 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.47472512 |
| 37 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.44360118 |
| 38 | response to host immune response (GO:0052572) | 3.44360118 |
| 39 | regulation of cholesterol storage (GO:0010885) | 3.42127138 |
| 40 | pinocytosis (GO:0006907) | 3.41121947 |
| 41 | cellular extravasation (GO:0045123) | 3.40532431 |
| 42 | detection of other organism (GO:0098543) | 3.40213321 |
| 43 | cell adhesion mediated by integrin (GO:0033627) | 3.37759628 |
| 44 | detection of molecule of bacterial origin (GO:0032490) | 3.27408600 |
| 45 | N-acetylneuraminate metabolic process (GO:0006054) | 3.26112233 |
| 46 | respiratory burst (GO:0045730) | 3.25997538 |
| 47 | detection of external biotic stimulus (GO:0098581) | 3.24902319 |
| 48 | wound healing, spreading of epidermal cells (GO:0035313) | 3.22546498 |
| 49 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.21336822 |
| 50 | response to host (GO:0075136) | 3.21336822 |
| 51 | response to host defenses (GO:0052200) | 3.21336822 |
| 52 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.19429115 |
| 53 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.17106277 |
| 54 | positive regulation of mast cell degranulation (GO:0043306) | 3.17106277 |
| 55 | glycolipid catabolic process (GO:0019377) | 3.16785982 |
| 56 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.16538709 |
| 57 | hyaluronan catabolic process (GO:0030214) | 3.07125385 |
| 58 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.03186183 |
| 59 | response to lipoprotein particle (GO:0055094) | 3.02268622 |
| 60 | peptide catabolic process (GO:0043171) | 3.01684625 |
| 61 | sequestering of metal ion (GO:0051238) | 3.00662236 |
| 62 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.98629797 |
| 63 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.96771194 |
| 64 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.95896006 |
| 65 | neutrophil activation (GO:0042119) | 2.94460075 |
| 66 | immunoglobulin mediated immune response (GO:0016064) | 2.94214973 |
| 67 | negative regulation of cell killing (GO:0031342) | 2.92404308 |
| 68 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.92404308 |
| 69 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.91209876 |
| 70 | regulation of mononuclear cell migration (GO:0071675) | 2.90881786 |
| 71 | granulocyte activation (GO:0036230) | 2.88789060 |
| 72 | detection of bacterium (GO:0016045) | 2.86807474 |
| 73 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.85851708 |
| 74 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.84685286 |
| 75 | ceramide catabolic process (GO:0046514) | 2.84483997 |
| 76 | detection of biotic stimulus (GO:0009595) | 2.82358058 |
| 77 | cellular response to vitamin (GO:0071295) | 2.82152714 |
| 78 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.81878853 |
| 79 | cellular response to vitamin D (GO:0071305) | 2.81200677 |
| 80 | myeloid cell activation involved in immune response (GO:0002275) | 2.80669533 |
| 81 | melanin biosynthetic process (GO:0042438) | 2.80473733 |
| 82 | positive regulation of receptor recycling (GO:0001921) | 2.80460088 |
| 83 | basement membrane organization (GO:0071711) | 2.78503142 |
| 84 | eosinophil chemotaxis (GO:0048245) | 2.77397579 |
| 85 | wound healing, spreading of cells (GO:0044319) | 2.73506003 |
| 86 | adhesion of symbiont to host cell (GO:0044650) | 2.73407423 |
| 87 | virion attachment to host cell (GO:0019062) | 2.73407423 |
| 88 | positive regulation of interferon-beta production (GO:0032728) | 2.72750335 |
| 89 | positive regulation of antigen processing and presentation (GO:0002579) | 2.72387859 |
| 90 | positive regulation of macrophage cytokine production (GO:0060907) | 2.70705105 |
| 91 | positive regulation of cholesterol efflux (GO:0010875) | 2.68448436 |
| 92 | regulation of antigen processing and presentation (GO:0002577) | 2.68350778 |
| 93 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.66727568 |
| 94 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.65546221 |
| 95 | positive regulation of leukocyte degranulation (GO:0043302) | 2.64877900 |
| 96 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.64333665 |
| 97 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.60355756 |
| 98 | regulation of gamma-delta T cell activation (GO:0046643) | 2.60097564 |
| 99 | intracellular pH reduction (GO:0051452) | 2.59973911 |
| 100 | positive regulation of chemokine secretion (GO:0090197) | 2.59352671 |
| 101 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.59338612 |
| 102 | cellular response to interferon-alpha (GO:0035457) | 2.58849946 |
| 103 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.58830831 |
| 104 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.58480859 |
| 105 | negative regulation of lipid storage (GO:0010888) | 2.58291528 |
| 106 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.57250278 |
| 107 | melanin metabolic process (GO:0006582) | 2.56923607 |
| 108 | regulation of mast cell activation (GO:0033003) | 2.56746321 |
| 109 | endodermal cell differentiation (GO:0035987) | 2.56225265 |
| 110 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.55750829 |
| 111 | lysosome organization (GO:0007040) | 2.55366551 |
| 112 | lytic vacuole organization (GO:0080171) | 2.55366551 |
| 113 | regulation of macrophage cytokine production (GO:0010935) | 2.54591009 |
| 114 | pH reduction (GO:0045851) | 2.54547395 |
| 115 | superoxide anion generation (GO:0042554) | 2.54398298 |
| 116 | low-density lipoprotein particle clearance (GO:0034383) | 2.52386818 |
| 117 | collagen fibril organization (GO:0030199) | 2.51956510 |
| 118 | phagosome maturation (GO:0090382) | 2.51600131 |
| 119 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.51499765 |
| 120 | positive regulation of cholesterol transport (GO:0032376) | 2.51466506 |
| 121 | positive regulation of sterol transport (GO:0032373) | 2.51466506 |
| 122 | regulation of mast cell degranulation (GO:0043304) | 2.51163444 |
| 123 | regulation of macrophage chemotaxis (GO:0010758) | 2.50922690 |
| 124 | membrane lipid catabolic process (GO:0046466) | 2.50769912 |
| 125 | low-density lipoprotein particle remodeling (GO:0034374) | 2.50535133 |
| 126 | adhesion of symbiont to host (GO:0044406) | 2.50002551 |
| 127 | T-helper 1 type immune response (GO:0042088) | 2.49706125 |
| 128 | membrane invagination (GO:0010324) | 2.49570994 |
| 129 | regulation of metalloenzyme activity (GO:0048552) | 2.48523510 |
| 130 | sphingolipid catabolic process (GO:0030149) | 2.48153658 |
| 131 | I-kappaB phosphorylation (GO:0007252) | 2.47059101 |
| 132 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.46905242 |
| 133 | positive regulation of chemokine production (GO:0032722) | 2.46304663 |
| 134 | regulation of leukocyte degranulation (GO:0043300) | 2.45815481 |
| 135 | eosinophil migration (GO:0072677) | 2.44630469 |
| 136 | protein maturation by protein folding (GO:0022417) | 2.44186018 |
| 137 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.43955487 |
| 138 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.43849476 |
| 139 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.43448029 |
| 140 | regulation of beta-amyloid formation (GO:1902003) | 2.42740491 |
| 141 | cellular response to unfolded protein (GO:0034620) | 2.42584413 |
| 142 | regulation of superoxide anion generation (GO:0032928) | 2.42445916 |
| 143 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.42142679 |
| 144 | negative regulation of interleukin-1 production (GO:0032692) | 2.42068317 |
| 145 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.41102586 |
| 146 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.40108420 |
| 147 | phagocytosis, recognition (GO:0006910) | 2.39948857 |
| 148 | reactive oxygen species biosynthetic process (GO:1903409) | 2.39599594 |
| 149 | regulation of platelet activation (GO:0010543) | 2.38782250 |
| 150 | negative regulation of interleukin-17 production (GO:0032700) | 2.38469018 |
| 151 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.35598843 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.60471945 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.65248720 |
| 3 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 4.42805555 |
| 4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.91515190 |
| 5 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.61002365 |
| 6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.57720519 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.47312339 |
| 8 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.26254153 |
| 9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.88425778 |
| 10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.86719504 |
| 11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.83446661 |
| 12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.59780148 |
| 13 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.52597771 |
| 14 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.39756413 |
| 15 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.38226500 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.32157714 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.31599234 |
| 18 | TFEB_21752829_ChIP-Seq_HELA_Human | 2.25576538 |
| 19 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.14876652 |
| 20 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 2.14328396 |
| 21 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 2.14328396 |
| 22 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.11444281 |
| 23 | CJUN_26792858_Chip-Seq_BT549_Human | 2.08234321 |
| 24 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.04165158 |
| 25 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.03672021 |
| 26 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.02244394 |
| 27 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 2.00813848 |
| 28 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.97968623 |
| 29 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.95709768 |
| 30 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.90618082 |
| 31 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.89250697 |
| 32 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.87459432 |
| 33 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.85971878 |
| 34 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.84059662 |
| 35 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.83293096 |
| 36 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.81127218 |
| 37 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.79990289 |
| 38 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.78851123 |
| 39 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.75397250 |
| 40 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.73574784 |
| 41 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72386113 |
| 42 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.72262998 |
| 43 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.64889091 |
| 44 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.59258157 |
| 45 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.59253991 |
| 46 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.57360458 |
| 47 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.52867102 |
| 48 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.45739795 |
| 49 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.45739795 |
| 50 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.45676760 |
| 51 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.44660096 |
| 52 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.42449325 |
| 53 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.41855002 |
| 54 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.41475558 |
| 55 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.41229715 |
| 56 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.41080841 |
| 57 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.41019371 |
| 58 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.38710608 |
| 59 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.37622263 |
| 60 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.36786155 |
| 61 | SPI1_23127762_ChIP-Seq_K562_Human | 1.33940864 |
| 62 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.33749225 |
| 63 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.30840474 |
| 64 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.30803927 |
| 65 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.30666402 |
| 66 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.28160004 |
| 67 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.27466658 |
| 68 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.26845839 |
| 69 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.22690354 |
| 70 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.21828039 |
| 71 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.21560437 |
| 72 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.21297813 |
| 73 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.20943310 |
| 74 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.20855628 |
| 75 | GATA1_22025678_ChIP-Seq_K562_Human | 1.20375102 |
| 76 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.20090917 |
| 77 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18798248 |
| 78 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.17607612 |
| 79 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.16080247 |
| 80 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.15924954 |
| 81 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15026443 |
| 82 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.14678793 |
| 83 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14052154 |
| 84 | GATA3_26560356_Chip-Seq_TH2_Human | 1.14010538 |
| 85 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.12028125 |
| 86 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.11717771 |
| 87 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.11196754 |
| 88 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.09871839 |
| 89 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09714310 |
| 90 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.08791632 |
| 91 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07824598 |
| 92 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.07795670 |
| 93 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.07338715 |
| 94 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06123598 |
| 95 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.04262748 |
| 96 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.01702697 |
| 97 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.99858289 |
| 98 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98735080 |
| 99 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98125592 |
| 100 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.98020518 |
| 101 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.98020518 |
| 102 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.98020518 |
| 103 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.98005465 |
| 104 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.97591336 |
| 105 | MYB_26560356_Chip-Seq_TH2_Human | 0.95768681 |
| 106 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94785146 |
| 107 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94753663 |
| 108 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.94576483 |
| 109 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.94576483 |
| 110 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.94348918 |
| 111 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.94055411 |
| 112 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.92938063 |
| 113 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92935399 |
| 114 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.90264000 |
| 115 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.90184241 |
| 116 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89861235 |
| 117 | * NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.88432276 |
| 118 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.87406020 |
| 119 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.86126599 |
| 120 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.86057125 |
| 121 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.85983893 |
| 122 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.85182764 |
| 123 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.85153068 |
| 124 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84686422 |
| 125 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.84051600 |
| 126 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.84041992 |
| 127 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.83994521 |
| 128 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.83867436 |
| 129 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.83596515 |
| 130 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.83277655 |
| 131 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.83067516 |
| 132 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.82164300 |
| 133 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.81030347 |
| 134 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.80751622 |
| 135 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.78233163 |
| 136 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.78101572 |
| 137 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.77453355 |
| 138 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.75611972 |
| 139 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.74264411 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 5.13566162 |
| 2 | MP0005058_abnormal_lysosome_morphology | 4.92652353 |
| 3 | MP0003172_abnormal_lysosome_physiology | 3.02346141 |
| 4 | MP0002877_abnormal_melanocyte_morpholog | 2.62268465 |
| 5 | MP0001835_abnormal_antigen_presentation | 2.53436704 |
| 6 | MP0003279_aneurysm | 2.50989193 |
| 7 | MP0006054_spinal_hemorrhage | 2.48554705 |
| 8 | MP0005275_abnormal_skin_tensile | 2.47518602 |
| 9 | MP0003436_decreased_susceptibility_to | 2.31276068 |
| 10 | MP0003705_abnormal_hypodermis_morpholog | 2.27755255 |
| 11 | MP0002419_abnormal_innate_immunity | 2.22037310 |
| 12 | MP0001958_emphysema | 2.21224583 |
| 13 | MP0005503_abnormal_tendon_morphology | 2.17540379 |
| 14 | MP0000372_irregular_coat_pigmentation | 2.14346368 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.12811756 |
| 16 | MP0006082_CNS_inflammation | 2.10153651 |
| 17 | MP0003183_abnormal_peptide_metabolism | 2.10007281 |
| 18 | MP0001533_abnormal_skeleton_physiology | 2.08849175 |
| 19 | MP0000569_abnormal_digit_pigmentation | 2.07972617 |
| 20 | MP0004272_abnormal_basement_membrane | 2.07916933 |
| 21 | MP0002148_abnormal_hypersensitivity_rea | 2.05738438 |
| 22 | MP0005257_abnormal_intraocular_pressure | 2.04263756 |
| 23 | MP0001542_abnormal_bone_strength | 1.93818427 |
| 24 | MP0000015_abnormal_ear_pigmentation | 1.90697919 |
| 25 | MP0003566_abnormal_cell_adhesion | 1.84910938 |
| 26 | MP0009840_abnormal_foam_cell | 1.73538656 |
| 27 | MP0002998_abnormal_bone_remodeling | 1.68646172 |
| 28 | MP0010386_abnormal_urinary_bladder | 1.67392575 |
| 29 | MP0002295_abnormal_pulmonary_circulatio | 1.64825695 |
| 30 | MP0003300_gastrointestinal_ulcer | 1.63289483 |
| 31 | MP0000371_diluted_coat_color | 1.62863305 |
| 32 | MP0004510_myositis | 1.62535949 |
| 33 | MP0003283_abnormal_digestive_organ | 1.61377394 |
| 34 | MP0000343_altered_response_to | 1.59461679 |
| 35 | MP0005000_abnormal_immune_tolerance | 1.57525623 |
| 36 | MP0005167_abnormal_blood-brain_barrier | 1.56815856 |
| 37 | MP0003724_increased_susceptibility_to | 1.52588459 |
| 38 | MP0003136_yellow_coat_color | 1.51441155 |
| 39 | MP0003690_abnormal_glial_cell | 1.50536496 |
| 40 | MP0005164_abnormal_response_to | 1.48826916 |
| 41 | MP0009384_cardiac_valve_regurgitation | 1.48430043 |
| 42 | MP0005390_skeleton_phenotype | 1.47504695 |
| 43 | MP0005171_absent_coat_pigmentation | 1.46878904 |
| 44 | MP0004883_abnormal_blood_vessel | 1.44792112 |
| 45 | MP0002837_dystrophic_cardiac_calcinosis | 1.44100824 |
| 46 | MP0003195_calcinosis | 1.42896072 |
| 47 | MP0009780_abnormal_chondrocyte_physiolo | 1.41461676 |
| 48 | MP0005174_abnormal_tail_pigmentation | 1.40878639 |
| 49 | MP0005075_abnormal_melanosome_morpholog | 1.37887266 |
| 50 | MP0009785_altered_susceptibility_to | 1.35800421 |
| 51 | MP0003329_amyloid_beta_deposits | 1.35756925 |
| 52 | MP0004130_abnormal_muscle_cell | 1.34068088 |
| 53 | MP0008260_abnormal_autophagy | 1.33087718 |
| 54 | MP0009764_decreased_sensitivity_to | 1.32836883 |
| 55 | MP0002452_abnormal_antigen_presenting | 1.31213677 |
| 56 | MP0001790_abnormal_immune_system | 1.30418538 |
| 57 | MP0005387_immune_system_phenotype | 1.30418538 |
| 58 | MP0002896_abnormal_bone_mineralization | 1.29704401 |
| 59 | MP0003795_abnormal_bone_structure | 1.29197178 |
| 60 | MP0005310_abnormal_salivary_gland | 1.27664064 |
| 61 | MP0003448_altered_tumor_morphology | 1.27135998 |
| 62 | MP0005464_abnormal_platelet_physiology | 1.26480988 |
| 63 | MP0003806_abnormal_nucleotide_metabolis | 1.25746732 |
| 64 | MP0000858_altered_metastatic_potential | 1.25730816 |
| 65 | MP0005451_abnormal_body_composition | 1.25565913 |
| 66 | MP0003045_fibrosis | 1.25496989 |
| 67 | MP0003303_peritoneal_inflammation | 1.25382165 |
| 68 | MP0002933_joint_inflammation | 1.25190046 |
| 69 | MP0005623_abnormal_meninges_morphology | 1.24875108 |
| 70 | MP0003075_altered_response_to | 1.24227460 |
| 71 | MP0003091_abnormal_cell_migration | 1.22293557 |
| 72 | MP0005025_abnormal_response_to | 1.20419239 |
| 73 | MP0005023_abnormal_wound_healing | 1.20227948 |
| 74 | MP0002139_abnormal_hepatobiliary_system | 1.19402544 |
| 75 | MP0004381_abnormal_hair_follicle | 1.19114376 |
| 76 | MP0003011_delayed_dark_adaptation | 1.14765254 |
| 77 | MP0003656_abnormal_erythrocyte_physiolo | 1.14582418 |
| 78 | MP0005165_increased_susceptibility_to | 1.13590616 |
| 79 | MP0004782_abnormal_surfactant_physiolog | 1.13584790 |
| 80 | MP0005670_abnormal_white_adipose | 1.13333130 |
| 81 | MP0010307_abnormal_tumor_latency | 1.12467763 |
| 82 | MP0008004_abnormal_stomach_pH | 1.11897412 |
| 83 | MP0005508_abnormal_skeleton_morphology | 1.11380301 |
| 84 | MP0002168_other_aberrant_phenotype | 1.11130301 |
| 85 | MP0001853_heart_inflammation | 1.09803706 |
| 86 | MP0005365_abnormal_bile_salt | 1.09187817 |
| 87 | MP0001545_abnormal_hematopoietic_system | 1.08649772 |
| 88 | MP0005397_hematopoietic_system_phenotyp | 1.08649772 |
| 89 | MP0001879_abnormal_lymphatic_vessel | 1.08341229 |
| 90 | MP0000604_amyloidosis | 1.07645154 |
| 91 | MP0000767_abnormal_smooth_muscle | 1.07244161 |
| 92 | MP0000013_abnormal_adipose_tissue | 1.06888504 |
| 93 | MP0004084_abnormal_cardiac_muscle | 1.05886415 |
| 94 | MP0000920_abnormal_myelination | 1.05812529 |
| 95 | MP0000685_abnormal_immune_system | 1.05385564 |
| 96 | MP0001845_abnormal_inflammatory_respons | 1.04241585 |
| 97 | MP0002060_abnormal_skin_morphology | 1.02680962 |
| 98 | MP0002090_abnormal_vision | 1.00782688 |
| 99 | MP0004947_skin_inflammation | 1.00343787 |
| 100 | MP0004036_abnormal_muscle_relaxation | 0.98531805 |
| 101 | MP0010352_gastrointestinal_tract_polyps | 0.98029623 |
| 102 | MP0002723_abnormal_immune_serum | 0.95710153 |
| 103 | MP0002971_abnormal_brown_adipose | 0.95333667 |
| 104 | MP0010155_abnormal_intestine_physiology | 0.94416983 |
| 105 | MP0002254_reproductive_system_inflammat | 0.94396044 |
| 106 | MP0002405_respiratory_system_inflammati | 0.94281769 |
| 107 | MP0004484_altered_response_of | 0.93722722 |
| 108 | MP0002693_abnormal_pancreas_physiology | 0.93300404 |
| 109 | MP0000249_abnormal_blood_vessel | 0.92739795 |
| 110 | MP0004215_abnormal_myocardial_fiber | 0.90247668 |
| 111 | MP0001851_eye_inflammation | 0.89263485 |
| 112 | MP0001819_abnormal_immune_cell | 0.89159259 |
| 113 | MP0005197_abnormal_uvea_morphology | 0.88610134 |
| 114 | MP0001324_abnormal_eye_pigmentation | 0.87612899 |
| 115 | MP0008469_abnormal_protein_level | 0.87578350 |
| 116 | MP0004019_abnormal_vitamin_homeostasis | 0.87172534 |
| 117 | MP0001243_abnormal_dermal_layer | 0.86745744 |
| 118 | MP0002420_abnormal_adaptive_immunity | 0.86336826 |
| 119 | MP0005666_abnormal_adipose_tissue | 0.82887073 |
| 120 | MP0001915_intracranial_hemorrhage | 0.82685986 |
| 121 | MP0010329_abnormal_lipoprotein_level | 0.81864306 |
| 122 | MP0002095_abnormal_skin_pigmentation | 0.81529189 |
| 123 | MP0009763_increased_sensitivity_to | 0.79659263 |
| 124 | MP0005166_decreased_susceptibility_to | 0.79505758 |
| 125 | MP0002909_abnormal_adrenal_gland | 0.79376759 |
| 126 | MP0000465_gastrointestinal_hemorrhage | 0.77982054 |
| 127 | MP0002972_abnormal_cardiac_muscle | 0.77639663 |
| 128 | MP0003646_muscle_fatigue | 0.77076971 |
| 129 | MP0000681_abnormal_thyroid_gland | 0.76798701 |
| 130 | MP0003632_abnormal_nervous_system | 0.76678233 |
| 131 | MP0001299_abnormal_eye_distance/ | 0.76618999 |
| 132 | MP0005408_hypopigmentation | 0.76338933 |
| 133 | * MP0002118_abnormal_lipid_homeostasis | 0.76220781 |
| 134 | MP0002115_abnormal_skeleton_extremities | 0.75813016 |
| 135 | MP0001756_abnormal_urination | 0.74086316 |
| 136 | MP0005671_abnormal_response_to | 0.73600515 |
| 137 | MP0009643_abnormal_urine_homeostasis | 0.73446454 |
| 138 | MP0003828_pulmonary_edema | 0.73314677 |
| 139 | MP0003634_abnormal_glial_cell | 0.73160457 |
| 140 | MP0005220_abnormal_exocrine_pancreas | 0.71179090 |
| 141 | MP0003950_abnormal_plasma_membrane | 0.69745837 |
| 142 | MP0001800_abnormal_humoral_immune | 0.69087889 |
| 143 | MP0002113_abnormal_skeleton_development | 0.68048129 |
| 144 | MP0002277_abnormal_respiratory_mucosa | 0.66812259 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased cerebral lipofuscin (HP:0011813) | 5.74013851 |
| 2 | Vacuolated lymphocytes (HP:0001922) | 5.70266496 |
| 3 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 5.55734911 |
| 4 | Dysostosis multiplex (HP:0000943) | 5.10482137 |
| 5 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.79605778 |
| 6 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.79605778 |
| 7 | Abnormality of glycolipid metabolism (HP:0010969) | 4.79605778 |
| 8 | Systemic lupus erythematosus (HP:0002725) | 4.74600094 |
| 9 | Mucopolysacchariduria (HP:0008155) | 4.30941293 |
| 10 | Urinary glycosaminoglycan excretion (HP:0003541) | 4.30941293 |
| 11 | Recurrent abscess formation (HP:0002722) | 4.18282174 |
| 12 | Cervical subluxation (HP:0003308) | 4.12178917 |
| 13 | Premature rupture of membranes (HP:0001788) | 4.03497061 |
| 14 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.91810479 |
| 15 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.91810479 |
| 16 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.91810479 |
| 17 | Glomerulonephritis (HP:0000099) | 3.69601474 |
| 18 | Recurrent bacterial skin infections (HP:0005406) | 3.58166828 |
| 19 | Eczematoid dermatitis (HP:0000976) | 3.51880561 |
| 20 | Vascular tortuosity (HP:0004948) | 3.46375617 |
| 21 | Vertebral compression fractures (HP:0002953) | 3.42988689 |
| 22 | Spondylolisthesis (HP:0003302) | 3.38482675 |
| 23 | Neurofibrillary tangles (HP:0002185) | 3.36686358 |
| 24 | Protrusio acetabuli (HP:0003179) | 3.30714701 |
| 25 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.28957732 |
| 26 | Arterial tortuosity (HP:0005116) | 3.28040022 |
| 27 | Purpura (HP:0000979) | 3.19400372 |
| 28 | Abnormality of macrophages (HP:0004311) | 3.17585524 |
| 29 | Cerebral aneurysm (HP:0004944) | 3.10134200 |
| 30 | Asymmetric septal hypertrophy (HP:0001670) | 3.07186469 |
| 31 | Mutism (HP:0002300) | 2.94477054 |
| 32 | Peritonitis (HP:0002586) | 2.88814419 |
| 33 | Osteolytic defects of the hand bones (HP:0009699) | 2.82494742 |
| 34 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.82494742 |
| 35 | Aortic aneurysm (HP:0004942) | 2.79397283 |
| 36 | Aortic dissection (HP:0002647) | 2.74761258 |
| 37 | Cerebral inclusion bodies (HP:0100314) | 2.74217505 |
| 38 | Pathologic fracture (HP:0002756) | 2.74205189 |
| 39 | Disinhibition (HP:0000734) | 2.74046912 |
| 40 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.72075609 |
| 41 | Axonal loss (HP:0003447) | 2.70180606 |
| 42 | Agnosia (HP:0010524) | 2.67304115 |
| 43 | Beaking of vertebral bodies (HP:0004568) | 2.67101375 |
| 44 | Spontaneous hematomas (HP:0007420) | 2.65562614 |
| 45 | Stomatitis (HP:0010280) | 2.61668938 |
| 46 | Orchitis (HP:0100796) | 2.60442347 |
| 47 | Amyloidosis (HP:0011034) | 2.58108334 |
| 48 | Soft skin (HP:0000977) | 2.56313133 |
| 49 | Albinism (HP:0001022) | 2.55722898 |
| 50 | Ocular albinism (HP:0001107) | 2.53520830 |
| 51 | Mediastinal lymphadenopathy (HP:0100721) | 2.52715355 |
| 52 | Progressive neurologic deterioration (HP:0002344) | 2.51268933 |
| 53 | Prolonged bleeding time (HP:0003010) | 2.50405017 |
| 54 | Petechiae (HP:0000967) | 2.48483606 |
| 55 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.47995226 |
| 56 | Myositis (HP:0100614) | 2.44980940 |
| 57 | Interstitial pulmonary disease (HP:0006530) | 2.39180886 |
| 58 | Increased CSF protein (HP:0002922) | 2.37851209 |
| 59 | Joint stiffness (HP:0001387) | 2.37623553 |
| 60 | Nephritis (HP:0000123) | 2.37617662 |
| 61 | Wormian bones (HP:0002645) | 2.32047103 |
| 62 | Global brain atrophy (HP:0002283) | 2.31902428 |
| 63 | Hematochezia (HP:0002573) | 2.31683708 |
| 64 | Abnormality of the periventricular white matter (HP:0002518) | 2.31261147 |
| 65 | Gingival bleeding (HP:0000225) | 2.30447750 |
| 66 | Autoimmune thrombocytopenia (HP:0001973) | 2.24863303 |
| 67 | Xanthomatosis (HP:0000991) | 2.24668682 |
| 68 | Retinal atrophy (HP:0001105) | 2.23668577 |
| 69 | Poor head control (HP:0002421) | 2.21582747 |
| 70 | Abnormality of complement system (HP:0005339) | 2.20171565 |
| 71 | Hypoplasia of the odontoid process (HP:0003311) | 2.18914432 |
| 72 | Optic neuritis (HP:0100653) | 2.16972084 |
| 73 | Retrobulbar optic neuritis (HP:0100654) | 2.16972084 |
| 74 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.16056843 |
| 75 | Thin bony cortex (HP:0002753) | 2.16030701 |
| 76 | Iris hypopigmentation (HP:0007730) | 2.15579070 |
| 77 | Chronic obstructive pulmonary disease (HP:0006510) | 2.14737358 |
| 78 | Obstructive lung disease (HP:0006536) | 2.14737358 |
| 79 | Hepatosplenomegaly (HP:0001433) | 2.12268034 |
| 80 | Myocardial infarction (HP:0001658) | 2.11949252 |
| 81 | Abnormality of dentin (HP:0010299) | 2.11484614 |
| 82 | Broad face (HP:0000283) | 2.11382335 |
| 83 | Atrophic scars (HP:0001075) | 2.09266769 |
| 84 | J-shaped sella turcica (HP:0002680) | 2.08260112 |
| 85 | Pulmonary infiltrates (HP:0002113) | 2.07348179 |
| 86 | Neuronal loss in central nervous system (HP:0002529) | 2.06024287 |
| 87 | Abnormality of the lumbar spine (HP:0100712) | 2.04796353 |
| 88 | Nausea (HP:0002018) | 2.04785580 |
| 89 | Diminished motivation (HP:0000745) | 2.02439883 |
| 90 | Apathy (HP:0000741) | 2.02323398 |
| 91 | Epistaxis (HP:0000421) | 2.02007371 |
| 92 | Ovoid vertebral bodies (HP:0003300) | 2.01618792 |
| 93 | Polyneuropathy (HP:0001271) | 2.01053189 |
| 94 | Blue sclerae (HP:0000592) | 2.01015356 |
| 95 | Short nail (HP:0001799) | 1.99771427 |
| 96 | Abnormality of the odontoid process (HP:0003310) | 1.99733889 |
| 97 | Loss of speech (HP:0002371) | 1.98557955 |
| 98 | Generalized hypopigmentation (HP:0007513) | 1.97558245 |
| 99 | Tetraparesis (HP:0002273) | 1.97140603 |
| 100 | Gingivitis (HP:0000230) | 1.94445269 |
| 101 | Keratoconjunctivitis sicca (HP:0001097) | 1.92719658 |
| 102 | Basal ganglia calcification (HP:0002135) | 1.91817258 |
| 103 | Nuclear cataract (HP:0100018) | 1.91589543 |
| 104 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.90746432 |
| 105 | Hemoptysis (HP:0002105) | 1.90451539 |
| 106 | White forelock (HP:0002211) | 1.88160162 |
| 107 | Progressive visual loss (HP:0000529) | 1.87638550 |
| 108 | Recurrent fungal infections (HP:0002841) | 1.87169612 |
| 109 | Femoral bowing (HP:0002980) | 1.85936582 |
| 110 | Conjunctival telangiectasia (HP:0000524) | 1.85476949 |
| 111 | Disproportionate short-trunk short stature (HP:0003521) | 1.85310254 |
| 112 | Blue irides (HP:0000635) | 1.84571010 |
| 113 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.84485776 |
| 114 | Ventricular fibrillation (HP:0001663) | 1.83299422 |
| 115 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.83244284 |
| 116 | Dilatation of the ascending aorta (HP:0005111) | 1.82872279 |
| 117 | Inappropriate behavior (HP:0000719) | 1.82192367 |
| 118 | Abnormality of skull ossification (HP:0002703) | 1.81410594 |
| 119 | Epidermoid cyst (HP:0200040) | 1.81325561 |
| 120 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.81114375 |
| 121 | Nonimmune hydrops fetalis (HP:0001790) | 1.80290758 |
| 122 | Ankle contracture (HP:0006466) | 1.80225270 |
| 123 | Peripheral demyelination (HP:0011096) | 1.79725031 |
| 124 | Complement deficiency (HP:0004431) | 1.79693861 |
| 125 | Episodic fever (HP:0001954) | 1.79463383 |
| 126 | Bone pain (HP:0002653) | 1.79189402 |
| 127 | Urticaria (HP:0001025) | 1.78110094 |
| 128 | Cardiomegaly (HP:0001640) | 1.77655186 |
| 129 | * Dementia (HP:0000726) | 1.77396571 |
| 130 | Bone cyst (HP:0012062) | 1.77385860 |
| 131 | Patchy hypopigmentation of hair (HP:0011365) | 1.77134613 |
| 132 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.77084020 |
| 133 | Shallow orbits (HP:0000586) | 1.77063429 |
| 134 | Platyspondyly (HP:0000926) | 1.77017648 |
| 135 | Mucosal telangiectasiae (HP:0100579) | 1.75469430 |
| 136 | Vertigo (HP:0002321) | 1.75395441 |
| 137 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.74952530 |
| 138 | Hypoplasia of the fovea (HP:0007750) | 1.74952530 |
| 139 | Recurrent skin infections (HP:0001581) | 1.74595598 |
| 140 | Keratoconjunctivitis (HP:0001096) | 1.73492557 |
| 141 | Thick nail (HP:0001805) | 1.72859543 |
| 142 | Increased serum ferritin (HP:0003281) | 1.72575343 |
| 143 | Osteomyelitis (HP:0002754) | 1.71559350 |
| 144 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 1.71227187 |
| 145 | Protuberant abdomen (HP:0001538) | 1.71134978 |
| 146 | Arterial thrombosis (HP:0004420) | 1.70486076 |
| 147 | Congenital sensorineural hearing impairment (HP:0008527) | 1.70243663 |
| 148 | Syncope (HP:0001279) | 1.70001617 |
| 149 | Follicular hyperkeratosis (HP:0007502) | 1.69683356 |
| 150 | Vasculitis (HP:0002633) | 1.66863459 |
| 151 | Abnormality of iron homeostasis (HP:0011031) | 1.65335229 |
| 152 | Biconcave vertebral bodies (HP:0004586) | 1.64238718 |
| 153 | Pulmonary embolism (HP:0002204) | 1.63456989 |
| 154 | Vertebral hypoplasia (HP:0008417) | 1.63036465 |
| 155 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.63036465 |
| 156 | Upper motor neuron abnormality (HP:0002127) | 1.61739251 |
| 157 | Abnormality of the frontal sinuses (HP:0002687) | 1.61393722 |
| 158 | Symptomatic seizures (HP:0011145) | 1.61102509 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TGFBR2 | 3.69773417 |
| 2 | IRAK4 | 3.18546920 |
| 3 | IRAK3 | 2.80860553 |
| 4 | BLK | 2.75621114 |
| 5 | NEK9 | 2.73886245 |
| 6 | ACVR1B | 2.60849580 |
| 7 | ERN1 | 2.52979584 |
| 8 | ERBB3 | 2.21093076 |
| 9 | MAP3K3 | 2.15061327 |
| 10 | MAP3K14 | 2.05262703 |
| 11 | PASK | 1.99979787 |
| 12 | FGR | 1.97935153 |
| 13 | PBK | 1.88204285 |
| 14 | TBK1 | 1.84910733 |
| 15 | FRK | 1.84261660 |
| 16 | SCYL2 | 1.81014237 |
| 17 | KIT | 1.80594010 |
| 18 | EPHA2 | 1.75175322 |
| 19 | TESK1 | 1.74724281 |
| 20 | CAMKK2 | 1.72441375 |
| 21 | INSRR | 1.70335883 |
| 22 | DDR2 | 1.70248977 |
| 23 | TYK2 | 1.63063384 |
| 24 | FLT3 | 1.60212307 |
| 25 | TRPM7 | 1.59133396 |
| 26 | MST4 | 1.55265980 |
| 27 | TRIB3 | 1.53770901 |
| 28 | PDGFRA | 1.38912156 |
| 29 | FES | 1.38528580 |
| 30 | MET | 1.37925691 |
| 31 | MAP2K3 | 1.37897870 |
| 32 | TAOK3 | 1.35656361 |
| 33 | PAK4 | 1.35184117 |
| 34 | SYK | 1.35146115 |
| 35 | PIM2 | 1.34768043 |
| 36 | MARK3 | 1.32586476 |
| 37 | CSF1R | 1.27865441 |
| 38 | MOS | 1.27673003 |
| 39 | ZAP70 | 1.26067593 |
| 40 | MAPK15 | 1.25626630 |
| 41 | STK10 | 1.22265890 |
| 42 | PIK3CG | 1.20785434 |
| 43 | PDK2 | 1.20291748 |
| 44 | MYLK | 1.20265170 |
| 45 | IKBKB | 1.19279175 |
| 46 | JAK3 | 1.18768496 |
| 47 | GRK7 | 1.18681830 |
| 48 | RIPK1 | 1.15351016 |
| 49 | TTN | 1.14835407 |
| 50 | CDC42BPA | 1.14802161 |
| 51 | EIF2AK3 | 1.12549348 |
| 52 | LIMK1 | 1.12470129 |
| 53 | PTK6 | 1.12046916 |
| 54 | ZAK | 1.11867127 |
| 55 | CSK | 1.11415597 |
| 56 | TEC | 1.11209882 |
| 57 | EPHB1 | 1.09734101 |
| 58 | TAOK1 | 1.09143994 |
| 59 | MAPK12 | 1.05825254 |
| 60 | JAK1 | 1.03525320 |
| 61 | PRPF4B | 1.02640411 |
| 62 | RPS6KA4 | 1.01691379 |
| 63 | MAP3K1 | 1.01146838 |
| 64 | MAPKAPK3 | 1.00601408 |
| 65 | DAPK2 | 1.00165033 |
| 66 | MAP3K5 | 0.98650299 |
| 67 | RIPK4 | 0.98570761 |
| 68 | EPHA3 | 0.98190068 |
| 69 | PDPK1 | 0.97538014 |
| 70 | MAP3K13 | 0.96104217 |
| 71 | LRRK2 | 0.95438548 |
| 72 | PTK2 | 0.93993779 |
| 73 | BMPR2 | 0.93935375 |
| 74 | MAP4K1 | 0.90510115 |
| 75 | FGFR3 | 0.88433811 |
| 76 | ADRBK2 | 0.87461038 |
| 77 | CHUK | 0.87359939 |
| 78 | MAP3K6 | 0.86805342 |
| 79 | PRKAA2 | 0.86239968 |
| 80 | BMPR1B | 0.85281074 |
| 81 | FER | 0.85009697 |
| 82 | CAMK1D | 0.84658185 |
| 83 | GRK6 | 0.83068716 |
| 84 | NME2 | 0.82325335 |
| 85 | PRKD1 | 0.81990076 |
| 86 | PDK1 | 0.81608694 |
| 87 | MAP3K11 | 0.81136161 |
| 88 | MAP3K2 | 0.80968242 |
| 89 | TXK | 0.78548424 |
| 90 | ITK | 0.74947848 |
| 91 | LYN | 0.74701469 |
| 92 | IGF1R | 0.74645216 |
| 93 | TNK2 | 0.73799535 |
| 94 | MAPK7 | 0.72164947 |
| 95 | PAK2 | 0.70997472 |
| 96 | MATK | 0.69465658 |
| 97 | MAP2K6 | 0.67740095 |
| 98 | STK24 | 0.67512545 |
| 99 | BTK | 0.67079258 |
| 100 | SGK3 | 0.66725041 |
| 101 | PTK2B | 0.66210544 |
| 102 | SGK2 | 0.66161137 |
| 103 | KSR2 | 0.65637804 |
| 104 | PRKCD | 0.64629653 |
| 105 | HCK | 0.63743440 |
| 106 | ARAF | 0.62253085 |
| 107 | YES1 | 0.62189187 |
| 108 | EGFR | 0.61384757 |
| 109 | MAPKAPK2 | 0.61048787 |
| 110 | TGFBR1 | 0.60709369 |
| 111 | CAMKK1 | 0.59785080 |
| 112 | NTRK1 | 0.59373937 |
| 113 | LCK | 0.58829717 |
| 114 | IRAK1 | 0.58673010 |
| 115 | PDGFRB | 0.58618416 |
| 116 | STK3 | 0.57339532 |
| 117 | IRAK2 | 0.57245975 |
| 118 | PRKCE | 0.56064465 |
| 119 | PRKG2 | 0.55325934 |
| 120 | PRKD3 | 0.54556646 |
| 121 | IKBKE | 0.52884854 |
| 122 | GSK3A | 0.50847520 |
| 123 | NEK6 | 0.50689326 |
| 124 | FYN | 0.50311124 |
| 125 | ABL2 | 0.50151857 |
| 126 | INSR | 0.49252226 |
| 127 | CDK6 | 0.48881582 |
| 128 | CDK8 | 0.48778142 |
| 129 | ABL1 | 0.48063665 |
| 130 | TAOK2 | 0.47795742 |
| 131 | RET | 0.47410459 |
| 132 | PKN2 | 0.47056239 |
| 133 | NUAK1 | 0.46759049 |
| 134 | PRKCH | 0.46677310 |
| 135 | PLK2 | 0.46380481 |
| 136 | MAPK4 | 0.45856888 |
| 137 | OBSCN | 0.43596167 |
| 138 | MST1R | 0.43519201 |
| 139 | BRSK2 | 0.43120113 |
| 140 | EIF2AK2 | 0.43008719 |
| 141 | JAK2 | 0.42322323 |
| 142 | PINK1 | 0.41998268 |
| 143 | PRKACG | 0.41547857 |
| 144 | RPS6KA2 | 0.41231949 |
| 145 | MARK2 | 0.38163549 |
| 146 | DMPK | 0.37651276 |
| 147 | TIE1 | 0.37064886 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Lysosome_Homo sapiens_hsa04142 | 4.17150281 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 4.05203299 |
| 3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.99706735 |
| 4 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.86415515 |
| 5 | Protein export_Homo sapiens_hsa03060 | 2.85077810 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.79670688 |
| 7 | Phagosome_Homo sapiens_hsa04145 | 2.58278331 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 2.12427029 |
| 9 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.05974789 |
| 10 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.99262388 |
| 11 | Legionellosis_Homo sapiens_hsa05134 | 1.96124329 |
| 12 | Pertussis_Homo sapiens_hsa05133 | 1.94482216 |
| 13 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.93474888 |
| 14 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.91628476 |
| 15 | Malaria_Homo sapiens_hsa05144 | 1.88783576 |
| 16 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.85039792 |
| 17 | Allograft rejection_Homo sapiens_hsa05330 | 1.82922816 |
| 18 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.81317766 |
| 19 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.77828492 |
| 20 | Tuberculosis_Homo sapiens_hsa05152 | 1.72433964 |
| 21 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.63691161 |
| 22 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.61387723 |
| 23 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.55023915 |
| 24 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.53044830 |
| 25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.46030288 |
| 26 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.45683338 |
| 27 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.44112849 |
| 28 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.41946072 |
| 29 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.35584217 |
| 30 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.29672049 |
| 31 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.28270741 |
| 32 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.25093853 |
| 33 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.24596137 |
| 34 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.20219903 |
| 35 | Amoebiasis_Homo sapiens_hsa05146 | 1.19358033 |
| 36 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.18118183 |
| 37 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.13583694 |
| 38 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.12547416 |
| 39 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.12203682 |
| 40 | Salmonella infection_Homo sapiens_hsa05132 | 1.11900693 |
| 41 | Shigellosis_Homo sapiens_hsa05131 | 1.10503185 |
| 42 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.09884858 |
| 43 | * Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.08092872 |
| 44 | Focal adhesion_Homo sapiens_hsa04510 | 1.07795254 |
| 45 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.06026515 |
| 46 | Prion diseases_Homo sapiens_hsa05020 | 1.04449520 |
| 47 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.02289307 |
| 48 | Apoptosis_Homo sapiens_hsa04210 | 1.00124465 |
| 49 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.96541543 |
| 50 | Measles_Homo sapiens_hsa05162 | 0.93726515 |
| 51 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.89443818 |
| 52 | Adherens junction_Homo sapiens_hsa04520 | 0.88782538 |
| 53 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.88292236 |
| 54 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.87481031 |
| 55 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.87155406 |
| 56 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.86719127 |
| 57 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.83876691 |
| 58 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.83257369 |
| 59 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.82676319 |
| 60 | Galactose metabolism_Homo sapiens_hsa00052 | 0.79116777 |
| 61 | Mineral absorption_Homo sapiens_hsa04978 | 0.78058747 |
| 62 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.77280848 |
| 63 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.77140899 |
| 64 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.76512815 |
| 65 | Endocytosis_Homo sapiens_hsa04144 | 0.74607562 |
| 66 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.71195539 |
| 67 | Influenza A_Homo sapiens_hsa05164 | 0.69435034 |
| 68 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.67229606 |
| 69 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.66906294 |
| 70 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.65756996 |
| 71 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.65008726 |
| 72 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.64844746 |
| 73 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.63936427 |
| 74 | Histidine metabolism_Homo sapiens_hsa00340 | 0.60810766 |
| 75 | Platelet activation_Homo sapiens_hsa04611 | 0.57708813 |
| 76 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.55841008 |
| 77 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.55622843 |
| 78 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.55295490 |
| 79 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.54342893 |
| 80 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.54206944 |
| 81 | Hepatitis B_Homo sapiens_hsa05161 | 0.53642132 |
| 82 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.53139323 |
| 83 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.52821401 |
| 84 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.52482955 |
| 85 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.52087384 |
| 86 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.50903111 |
| 87 | Hepatitis C_Homo sapiens_hsa05160 | 0.49379753 |
| 88 | Insulin resistance_Homo sapiens_hsa04931 | 0.47876395 |
| 89 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.46721647 |
| 90 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.46621684 |
| 91 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.45681397 |
| 92 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.45652050 |
| 93 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.45165994 |
| 94 | Viral myocarditis_Homo sapiens_hsa05416 | 0.44253909 |
| 95 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.44219119 |
| 96 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.44165565 |
| 97 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.43977861 |
| 98 | Renin secretion_Homo sapiens_hsa04924 | 0.43336823 |
| 99 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.43128600 |
| 100 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.42791850 |
| 101 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.41155713 |
| 102 | Prostate cancer_Homo sapiens_hsa05215 | 0.40994496 |
| 103 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.40719616 |
| 104 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.39897243 |
| 105 | Melanoma_Homo sapiens_hsa05218 | 0.39400135 |
| 106 | ABC transporters_Homo sapiens_hsa02010 | 0.39091034 |
| 107 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.38891070 |
| 108 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.38586597 |
| 109 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.37531201 |
| 110 | * Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.37219360 |
| 111 | Bladder cancer_Homo sapiens_hsa05219 | 0.37149256 |
| 112 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.35607161 |
| 113 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.35030211 |
| 114 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.34941247 |
| 115 | Asthma_Homo sapiens_hsa05310 | 0.34681075 |
| 116 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.34612024 |
| 117 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.34293929 |
| 118 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.33796104 |
| 119 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.33323566 |
| 120 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.33018625 |
| 121 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.31704054 |
| 122 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.31462305 |
| 123 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.31422158 |
| 124 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.30321831 |
| 125 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.30265276 |
| 126 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.30232058 |
| 127 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.24998976 |
| 128 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.24665673 |
| 129 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.23433193 |
| 130 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.23398027 |
| 131 | Pathways in cancer_Homo sapiens_hsa05200 | 0.22321350 |
| 132 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.21364205 |
| 133 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.21256611 |
| 134 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.19950664 |

